Guy Lucas

Eradication of Minimal Residual Disease in B-Cell Chronic Lymphocytic Leukemia After Alemtuzumab Therapy Is Associated With Prolonged Survival

Paul Moreton, Ben Kennedy, Guy Lucas et al. · Journal of Clinical Oncology · 2005 · 421 citations

Medicine, Hematology, Oncology +16

A Gain-of-Function Mutation in the <i>HIF2A</i> Gene in Familial Erythrocytosis

Melanie J. Percy, Paul W. Furlow, Guy Lucas et al. · New England Journal of Medicine · 2008 · 312 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Campath-1H and fludarabine in combination are highly active in refractory chronic lymphocytic leukemia

Ben Kennedy, Andy C. Rawstron, Mary Ryan et al. · Blood · 2002 · 190 citations · Full text

Medicine, Oncology, Pharmacology +12

Molecular quantitation of minimal residual disease in acute myeloid leukemia with t(8;21) can identify patients in durable remission and predict clinical relapse

Khalid Tobal, Joseph Newton, Mac Macheta et al. · Blood · 2000 · 147 citations

Medicine, Hematology, Oncology +17

Cardiopulmonary function in two human disorders of the hypoxia‐inducible factor (HIF) pathway: von Hippel‐Lindau disease and HIF‐2α gain‐of‐function mutation

Federico Formenti, Philip Beer, Quentin P. P. Croft et al. · The FASEB Journal · 2011 · 91 citations · Full text

Medicine, Genetics, Molecular Genetics +15